Small intestine and microbiota

Current Opinion in Gastroenterology

Volumn 27, Issue 2, 2011, Pages 99-105

  Cotter, Paul D ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

celiac disease; composition; inflammatory bowel disease; irritable bowel syndrome; microbiota; pouchitis; small intestine

Indexed keywords

ANASTOMOSIS; BACTEROIDES; CELIAC DISEASE; CLOSTRIDIUM; CROHN DISEASE; ENTERITIS; ESCHERICHIA COLI; HUMAN; ILEITIS; ILEOSTOMY; INTESTINE FLORA; INTESTINE TRANSPLANTATION; IRRITABLE COLON; MYCOBACTERIUM PARATUBERCULOSIS; PEDIATRICS; REVIEW; SMALL INTESTINE; STAPHYLOCOCCUS; ULCERATIVE COLITIS;

CELIAC DISEASE; HUMANS; ILEOSTOMY; INFLAMMATORY BOWEL DISEASES; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; POUCHITIS;

EID: 79951679485     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328341dc67     Document Type: Review

References (60)

1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human (Pubitemid 43261456)
2. Booijink CC, Zoetendal EG, Kleerebezem M, de Vos WM. Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol 2007; 2:285-295. (Pubitemid 47180925)
3. Zoetendal EG, Collier CT, Koike S, et al. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr 2004; 134:465-472. (Pubitemid 38141834)
4. O'Toole PW, Claesson MJ. Gut microbiota: changes throughout the lifespan from infancy to elderly. Int Dairy J 2010; 20:281-291.
5. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346:180-188. (Pubitemid 34438885)
6. Tjellstrom B, Stenhammar L, Hogberg L, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 2005; 100:2784-2788.
7. Sanz Y, Sanchez E, Marzotto M, et al. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol 2007; 51:562-568. (Pubitemid 350076169)
8. Fasano A, Catassi C. Coeliac disease in children. Best Pract Res Clin Gastroenterol 2005; 19:467-478. (Pubitemid 40753766)
9. Collado MC, Donat E, Ribes-Koninckx C, et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009; 62:264-269.
10. De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 2010; 10:63.
11. Schippa S, Iebba V, Barbato M, et al. A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol 2010; 10:175.
12. Collado MC, Calabuig M, Sanz Y. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol 2007; 8:9-14. (Pubitemid 46604951)
13. Forsberg G, Fahlgren A, Horstedt P, et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 2004; 99:894-904. (Pubitemid 39090220)
14. Ou G, Hedberg M, Horstedt P, et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol 2009; 104:3058-3067.
15. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124:1767-1773. (Pubitemid 36666773)
16. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52:237-242. (Pubitemid 36115065)
17. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-13785. (Pubitemid 350003397)
18. Sokol H, Seksik P, Rigottier-Gois L, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:106-111.
19. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405-1413. (Pubitemid 28545991)
20. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-421. (Pubitemid 39091889)
21. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566-1574. (Pubitemid 46871341)
22. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 2007; 87:1042-1054. (Pubitemid 47429187)
23. Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 2008; 14:858-867. (Pubitemid 351898071)
24. Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004; 364:1039-1044. (Pubitemid 39248662)
25. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn's disease: detection by laser capture microdissection and PCR. Am J Gastroenterol 2004; 99:1539-1543. (Pubitemid 39180104)
26. Bevins CL, Stange EF, Wehkamp J. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut 2009; 58:882-883.
27. Simms LA, Doecke JD, Walsh MD, et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008; 57:903-910. (Pubitemid 351919524)
28. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alphadefensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005; 102:18129-18134. (Pubitemid 41798513)
29. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307:731-734. (Pubitemid 40194644)
30. Petnicki-Ocwieja T, Hrncir T, Liu YJ, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 2009; 106:15813-15818.
31. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-16736.
32. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007; 1:403-418. (Pubitemid 47373247)
33. Vasquez N, Mangin I, Lepage P, et al. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosaassociated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis 2007; 13:684-692. (Pubitemid 46909982)
34. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006; 12:1136-1145. (Pubitemid 44847471)
35. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14:147-161. (Pubitemid 351288036)
36. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009; 15:653-660.
37. Willing B, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that GI microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010. [Epub ahead of print]
38. Booijink CC, El-Aidy S, Rajilic-Stojanovic M, et al. High temporal and interindividual variation detected in the human ileal microbiota. Environ Microbiol 2010. [Epub ahead of print]
39. Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A 2009; 106:17187-17192.
40. Nayyar N, Mazariegos G, Ranganathan S, et al. Pediatric small bowel transplantation. Semin Pediatr Surg 2010; 19:68-77.
41. Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J Clin Gastroenterol 2004; 38:S44-S50. (Pubitemid 38544543)
42. Coffey JC, Rowan F, Burke J, et al. Pathogenesis of and unifying hypothesis for idiopathic pouchitis. Am J Gastroenterol 2009; 104:1013-1023.
43. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998; 85:800-803. (Pubitemid 28300513)
44. Lovegrove RE, Tilney HS, Heriot AG, et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 2006; 49:1293-1306. (Pubitemid 44401377)
45. Navaneethan U, Shen B. Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010; 105:51-64.
46. Duffy M, O'Mahony L, Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002; 45:384-388. (Pubitemid 34273621)
47. Komanduri S, Gillevet PM, Sikaroodi M, et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007; 5:352-360. (Pubitemid 46401536)
48. Falk A, Olsson C, Ahrne S, et al. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007; 42:973-985. (Pubitemid 47037119)
49. Lim M, Adams JD, Wilcox M, et al. An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota. Dis Colon Rectum 2009; 52:1492-1500.
50. Smith FM, Coffey JC, Kell MR, et al. A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis 2005; 7:563-570. (Pubitemid 41631616)
51. Zella GC, Hait EJ, Glavan T, et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis 2010. [Epub ahead of print]
52. McLaughlin SD, Walker AW, Churcher C, et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg 2010; 252:90-98.
53. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130:1480-1491.
54. Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for postinfectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138:1502-1513.
55. Malinen E, Krogius-Kurikka L, Lyra A, et al. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010; 16:4532-4540.
56. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373-382. (Pubitemid 40314522)
57. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24-33. (Pubitemid 47031125)
58. Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15:2887-2892.
59. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-551. (Pubitemid 40585355)
60. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004; 38:S104-S106.